New Year, New Guidelines

High grade and metastatic pheo/para guidelines (mPPGL) panels met via video and conference call throughout the year and convened in person for a two-day meeting prior to Symposium.  Each panelist presented the latest research and developments for review and discussion. mPPGL is completing an internal survey to gauge consensus among the group. Both panels are on track to reach consensus and to publish guidelines in 2020. Chairs and panelists include:

Pheo/Para Workgroup
 The co-chairs are: Lauren Fishbein, MD, Ph.D., University of Colorado School of Medicine; Jaydira Del Rivero, MD, National Cancer Institute, National Institutes of Health; and Camilo Jimenez, MD, University of Texas, MD Anderson Cancer Center. Panelists include: Sylvia Asa, MD, Ph.D., University Health Network, Toronto; Debbie Cohen, MBBCH, University of Pennsylvania; Patricia Dahia, MD, Ph.D., University of Texas Health, San Antonio; Tobias Else, MD, University of Michigan; Douglas L. Fraker, MD, University of Pennsylvania; Karyn Goodman, MD, MS, University of Colorado, Denver; Thomas Hope, MD, University of California, San Francisco; James Howe, MD, University of Iowa, Carver College of Medicine; Pamela L. Kunz, MD, Stanford University Medical Center; Kimberly Perez, MD, Dana Farber Cancer Institute; Nancy Perrier, MD, FACS, University of Texas, MD Anderson Cancer Center; Daniel A. Pryma, MD, University of Pennsylvania, Perelman School of Medicine; Mabel Ryder, MD, Mayo Clinic; and Michael Soulen, MD, Abramson Cancer Center, University of Pennsylvania.

High Grade NEN Workgroup
The chair is Jennifer Eads, MD,
University of Pennsylvania. Panelists include: Timothy Asmis, MD, FRCPC, University of Ottawa; Andrew Bellizzi, MD, University of Iowa, Carver College of Medicine; Emily Bergsland, MD, University of California, San Francisco; Jennifer Chan, MD, MPH, Dana Farber Cancer Institute; Arvind Dasari, MD, MD Anderson Cancer Center; Ghassan El Haddad, MD, Moffitt Cancer Center; Michael Frumovitz, MD, MD Anderson Cancer Center; Thorvardur R. Halfdanarson, MD, Mayo Clinic; Joshua E. Meyer, MD, Fox Chase Cancer Center; Erik S. Mittra, MD, Ph.D., Oregon Health Sciences University; Sten Myrehaug, MD, FRCPC, University of Toronto; Eric Nakakura, MD, Ph.D., University of California, San Francisco; Nitya Raj, MD, Memorial Sloan Kettering Cancer Center; Heloisa Soares, MD, University of New Mexico; Laura Tang, MD, DO, Memorial Sloan Kettering Cancer Center; Brian Untch, MD, FACS, Memorial Sloan Kettering Cancer Center; and Neena Vijayvergia, MD, Fox Chase Cancer Center.


  • The joint NANETS/SNMMI consensus guidelines for PRRT were published in The Journal of Nuclear Medicine, 2019 60:8A.
  • The second joint NANETS/SNMMI PRRT guidelines are scheduled to be published in the January 2020 issue of The Journal of Nuclear Medicine.
  • Surgical Management of Pancreatic Neuroendocrine Tumors has been published in the January 2020 issue of Pancreas. (See article below.) 
  • The second pancreatic guidelines manuscript was completed and is under review by the committee with an expected to be submitted for publication before the end of the year.

2020 Consensus Guidelines Goals:

  • Complete and publish Para/Pheo consensus guidelines
  • Complete and publish High Grade NET consensus guidelines
  • Publish both pNETs consensus guidelines and distribute to the NET community
  • Support publication of Lung NETS guidelines
  • Recommend 2020/2021 guideline priorities
  • Host pNETs guidelines webinars